Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, Krakow 30-387, Poland.
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, Krakow 30-387, Poland.
Vascul Pharmacol. 2019 Jan;112:42-53. doi: 10.1016/j.vph.2018.08.009. Epub 2018 Aug 28.
Aging is the most critical risk factor for the development of cardiovascular diseases and their complications. Therefore, the fine-tuning of cellular response to getting older is an essential target for prospective therapies in cardiovascular medicine. One of the most promising targets might be the transcription factor Nrf2, which drives the expression of cytoprotective and antioxidative genes. Importantly, Nrf2 expression correlates with potential lifespan in rodents. However, the effect of Nrf2 activity in vascular diseases might be ambiguous and strongly depend on the cell type. On the one hand, the Nrf2 activity may protect cells from oxidative stress and senescence, on the other hand, total lack of Nrf2 is protective against atherosclerosis development. Therefore, this review aims to discuss the current knowledge on the role played by the transcription factor Nrf2 in cardiovascular diseases and its potential effects on aging.
衰老是心血管疾病及其并发症发展的最关键风险因素。因此,精细调节细胞对衰老的反应是心血管医学中潜在治疗的重要目标。最有前途的靶点之一可能是转录因子 Nrf2,它驱动细胞保护和抗氧化基因的表达。重要的是,Nrf2 的表达与啮齿动物的潜在寿命相关。然而,Nrf2 活性在血管疾病中的作用可能是模糊的,并强烈依赖于细胞类型。一方面,Nrf2 活性可以保护细胞免受氧化应激和衰老,另一方面,完全缺乏 Nrf2 可防止动脉粥样硬化的发展。因此,本综述旨在讨论转录因子 Nrf2 在心血管疾病中的作用及其对衰老的潜在影响的最新知识。